NovaBay Pharmaceuticals, Inc.

Total Valuation

NovaBay Pharmaceuticals, Inc. carries a market capitalization of 39.14M, placing it among publicly traded companies globally. Its enterprise value stands at -3.69M, reflecting the total theoretical takeover cost after accounting for cash holdings and debt obligations.

Share Statistics

NovaBay Pharmaceuticals, Inc. currently has 26.72M shares outstanding.

Valuation Ratios

NovaBay Pharmaceuticals, Inc. trades at a trailing price-to-earnings ratio of 0.03. The price-to-sales ratio is 5.72, and the price-to-book ratio stands at -0.05.

Enterprise Valuation

Financial Position

NovaBay Pharmaceuticals, Inc. maintains a current ratio of 5.33, meaning it holds 5.3x the short-term assets needed to cover near-term liabilities. The debt-to-equity ratio is 0.46, indicating conservative leverage, while an interest coverage ratio of -18.71 demonstrates limited ability to service its debt obligations.

Financial Efficiency

Taxes

Over the trailing twelve months, NovaBay Pharmaceuticals, Inc. has paid 3.45M in income taxes, reflecting an effective tax rate of 0.66.

Stock Price Statistics

NovaBay Pharmaceuticals, Inc.'s stock has declined approximately -48.42456% over the past 52 weeks. The 50-day moving average sits at 3.53, while the 200-day moving average is 9.62.

Income Statement

Over the trailing twelve months, NovaBay Pharmaceuticals, Inc. generated 2.46M in revenue and converted that into 522.59M in net income, yielding earnings per share of 9.33. EBITDA reached -5.18M, while operating income came in at -5.27M.

Balance Sheet

NovaBay Pharmaceuticals, Inc. holds 18.41M in cash and equivalents against 637,000.00 in total debt, resulting in a net debt position of -18.40M. Total book value stands at -266.38M, with working capital of 15.48M providing operational flexibility.

Cash Flow

NovaBay Pharmaceuticals, Inc. produced -8.91M in operating cash flow over the past twelve months.

Margins

NovaBay Pharmaceuticals, Inc. operates with a gross margin of 80.55, reflecting its pricing power and cost economics. The operating margin of -213.93 and net profit margin of 21,217.70 provide insight into operational efficiency.

Dividends & Yields

The company's payout ratio of 0.00 indicates the proportion of earnings distributed to shareholders.

Stock Splits

NovaBay Pharmaceuticals, Inc.'s most recent stock split took place on February 23, 2026 with a 5:1 split ratio.

Scores

NovaBay Pharmaceuticals, Inc. posts an Altman Z-Score of -18.60, below the 3.0 threshold that indicates strong financial health and minimal bankruptcy risk.